Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/12/2025
Insiders say that banks such as Morgan Stanley, JPMorgan Chase, and Goldman Sachs are promoting their businesses to space exploration technology companies.
Latest
1 m ago
Gene Tech: Announces agreement with the US government, specific terms of the agreement are still confidential. The government will exclude Gene Tech's product portfolio from tariff range. The flu drug product line will be supplied through the TrumpRX.gov website, and can also be obtained through the company's recently launched direct-to-patient program. Gene Tech announces a $50 billion investment in US manufacturing.
2 m ago
Novartis Pharmaceuticals: Reaches agreement with the US government to lower drug prices in the US. Will invest $23 billion in research and manufacturing in the US. Announces the establishment of a $1.1 billion research center in San Diego.
5 m ago
Sanofi: Will reduce the prices of certain drugs used in the United States to treat diabetes, cardiovascular and neurological diseases, as well as cancer by an average of 61%.
6 m ago
American President Trump: Tariff threats force pharmaceutical companies to reach agreements.
6 m ago
Amgen: Working with the US government to take action to lower the cost of drugs for American patients. Since 2018, Amgen has invested over $40 billion in manufacturing and research and development. It will expand its "direct-to-patient" program AmgenNow to include Aimovig and Amjevita. All three drugs will also be available through TRUMPRX.GOV. Aimovig and Amjevita will be offered at a discounted price of $299 per month.
See all latest